Business · 24/11/2025Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of OCALIVA Tablets from Intercept Pharmaceuticals and Other Holders
Summary
The FDA is withdrawing approval of OCALIVA (obeticholic acid) tablets, 5mg and 10mg, from Intercept Pharmaceuticals and three other holders, following voluntary requests from the companies.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →